Jan Bogers

975 total citations
35 papers, 468 citations indexed

About

Jan Bogers is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, Jan Bogers has authored 35 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 5 papers in Biological Psychiatry. Recurrent topics in Jan Bogers's work include Schizophrenia research and treatment (26 papers), Psychiatric care and mental health services (5 papers) and Tryptophan and brain disorders (5 papers). Jan Bogers is often cited by papers focused on Schizophrenia research and treatment (26 papers), Psychiatric care and mental health services (5 papers) and Tryptophan and brain disorders (5 papers). Jan Bogers collaborates with scholars based in Netherlands, United Kingdom and United States. Jan Bogers's co-authors include Peter F.J. Schulte, Dan Cohen, D. van Dijk, Egbert Bakker, Lieuwe de Haan, Hong N. Bui, Dan Cohen, Jentien M. Vermeulen, Jean-Paul Selten and Selene Veerman and has published in prestigious journals such as Psychological Medicine, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Jan Bogers

33 papers receiving 458 citations

Peers

Jan Bogers

PMH

PHILO

GENET

Corina Young United Kingdom

Mallik Greene United States

Maila Majak Sweden

Hsien-Jane Chiu Taiwan

Sainza García Spain

Ari Jaffe United States

F Casadebaig France

Na Jin China

Eleni Vradi Denmark

Jacqueline Zummo United States

Corina Young United Kingdom

Jan Bogers

530 ×1.8

PMH

102 ×1.3

37 ×0.6

154 ×2.4

PHILO

36 ×0.7

GENET

Citations per year, relative to Jan Bogers Jan Bogers (= 1×) peers Corina Young

Countries citing papers authored by Jan Bogers

Since Specialization

Citations

This map shows the geographic impact of Jan Bogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Bogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Bogers more than expected).

Fields of papers citing papers by Jan Bogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Bogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Bogers. The network helps show where Jan Bogers may publish in the future.

Co-authorship network of co-authors of Jan Bogers

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Bogers. A scholar is included among the top collaborators of Jan Bogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Bogers. Jan Bogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bogers, Jan. (2025). Antipsychotic treatment in schizophrenia: balancing relapse prevention and functional recovery. Schizophrenia. 11(1). 154–154.

Gillespie, Amy, Emma Walker, Eilís Hannon, et al.. (2024). Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts. Translational Psychiatry. 14(1). 390–390. 3 indexed citations

Bogers, Jan, et al.. (2024). Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia. Journal of Clinical Medicine. 13(7). 2112–2112. 3 indexed citations

Schulte, Peter F.J., et al.. (2023). Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?. Schizophrenia Research. 268. 74–81. 4 indexed citations

Veerman, Selene, et al.. (2022). Clozapine and COVID‐19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study. Acta Psychiatrica Scandinavica. 146(2). 168–178. 15 indexed citations

Ottenheim, Nathaly Rius, Johanna M. Geleijnse, Ondine van de Rest, et al.. (2022). Effects of multivitamin, mineral and n-3 polyunsaturated fatty acid supplementation on aggression among long-stay psychiatric in-patients: randomised clinical trial. BJPsych Open. 8(2). e42–e42. 2 indexed citations

Horowitz, Mark, Joanna Moncrieff, Lieuwe de Haan, et al.. (2021). Tapering antipsychotic medication: practical considerations. Psychological Medicine. 52(1). 32–35. 16 indexed citations

Bogers, Jan, et al.. (2020). The incidence and economic impact of aggression in closed long-stay psychiatric wards. International Journal of Psychiatry in Clinical Practice. 25(4). 430–436. 7 indexed citations

Selten, Jean-Paul, et al.. (2020). Migration and dementia: a meta-analysis of epidemiological studies in Europe. Psychological Medicine. 51(11). 1838–1845. 32 indexed citations

10.

Schulte, Peter F.J., et al.. (2020). Delegating Clozapine Monitoring to Advanced Nurse Practitioners: An Exploratory, Randomized Study to Assess the Effect on Prescription and Its Safety. Administration and Policy in Mental Health and Mental Health Services Research. 47(4). 632–640. 5 indexed citations

11.

Bogers, Jan, et al.. (2020). Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin Open. 1(1). 20 indexed citations

12.

Bogers, Jan, Peter F.J. Schulte, Theo G. Broekman, P. Moleman, & Lieuwe de Haan. (2018). Dose reduction of high-dose first-generation antipsychotics or switch to ziprasidone in long-stay patients with schizophrenia: A 1-year double-blind randomized clinical trial. European Neuropsychopharmacology. 28(9). 1024–1034. 8 indexed citations

13.

Termorshuizen, Fabian, Peter F.J. Schulte, Jan Bogers, et al.. (2018). Prescription and Underprescription of Clozapine in Dutch Ambulatory Care. Frontiers in Psychiatry. 9. 231–231. 6 indexed citations

14.

Weide, Karen van der, Harriët M. Loovers, Kirsten M. Pondman, et al.. (2016). Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. The Pharmacogenomics Journal. 17(5). 471–478. 23 indexed citations

15.

Bogers, Jan, et al.. (2014). Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device. European Neuropsychopharmacology. 25(3). 319–324. 39 indexed citations

16.

Bogers, Jan, et al.. (2013). Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis. General Hospital Psychiatry. 35(5). 576.e11–576.e12. 14 indexed citations

17.

Cohen, Dan, Jan Bogers, D. van Dijk, Egbert Bakker, & Peter F.J. Schulte. (2012). Beyond White Blood Cell Monitoring. The Journal of Clinical Psychiatry. 73(10). 1307–1312. 108 indexed citations

18.

Bogers, Jan, et al.. (2011). Interaction of St John’s wort (Hypericum perforatum) with clozapine. International Clinical Psychopharmacology. 27(2). 121–124. 42 indexed citations

19.

Schulte, Peter F.J., et al.. (2007). Compulsory treatment with clozapine: A retrospective long-term cohort study. International Journal of Law and Psychiatry. 30(6). 539–545. 12 indexed citations

20.

Bogers, Jan, Joop de Jong, & Ivan H. Komproe. (2000). Schizophrenia among Surinamese in the Netherlands: high admission rates not explained by high emigration rates. Psychological Medicine. 30(6). 1425–1431. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact